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Abstract
In South Africa today, it is estimated that there are 6.5 million people living with
HIV/AIDS, at least half a million of whom require urgent treatment. On the continent of
Africa as a whole the numbers are even more startling. Unfortunately, although the South
African government has now committed itself to rolling out anti-retroviral therapy
through the public healthcare system, progress has been slower than expected. Yet in
numerous sites around South Africa, rollout centres have been established successfully,
even in the most rural parts of the country. These programmes rely on existing
community initiatives, community health workers and volunteers, and positive people
themselves to educate, counsel, and monitor ARV patients.
In this study I suggest that this model of care can be extremely empowering for
the patient and reconceptualises healthcare as a path to social change. Drawing primarily
from the examples of Madwaleni Hospital in the Eastern Cape, and the Edendale
community in KwaZulu-Natal. I examine the dynamics of ARV programmes and the
ways in which they create the "empowered patient"-- one who is knowledgeable,
articulate, and motivated to effect change in his/her personal life and the social conditions
under which he/she lives. Finally, I relate the idea of patient empowerment to a
philosophy of primary healthcare and analyse the potential of primary healthcare to
improve health in communities through permanent social transformation.
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Methods
I spent my ISP period in three different locations: Cape Town, the vicinity of
Edendale Hospital in KwaZulu-Natal, and Madwaleni Hospital in the Eastern Cape. My
work in Cape Town comprised mainly interviews and library research, while my work in
KZN and the Eastern Cape involved observation, interviews, and everyday interactions.

Cape Town
In Cape Town, I interviewed Gilles van Cutsem, a physician at the Khayelitsha
Site C clinic. I interviewed Gilles to gain a sense of how the doctor’s experience of
HIV/AIDS care has changed pre and post-ARVs. I was also interested in how he saw the
role of the medical doctor in the network of relationships that surround the sick in ARV
treatment. I also interviewed Andrew Boulle, a researcher at the UCT Medical School
and a physician in Khayelitsha, around similar topics, focusing more on delivery systems.

Edendale, KZN
In Edendale, I observed a three-day adherence training session run by a team from
BroadReach Healthcare (BRHC). BRHC is a non-governmental organization that utilizes
existing resources in communities in ARV rollout. They facilitate relationships between
private doctors, support groups, treatment buddies, and patients to ensure that patients
receive treatment, counseling, and psychological support. The three-day adherence
training session targets new members of BRHC’s ARV care programme. In those three
days, patients and their “treatment buddies” are educated on the nature and transmission
of HIV/AIDS, adherence to ARVs, possible side effects on ARVs, in preparation for the
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commencement of treatment on the fourth day after the sessions.
I also held a short focus group session with three members of the BRHC team-Bongani, Zendile, and Themba. All three of them work in different parts of the country,
coordinating the rollout effort at different sites and facilitating the enrolment process as
education sessions take place.
I lived in the home of Molly Kubheka, a support group leader. Thus I also gained
a great deal of information through formal and informal conversations with her. I also
spoke to a number of support group leaders, most significantly Nokuthula Biyela and
Sipho Mncwabe, all of whom act as community facilitators to BRHC.

Madwaleni Hospital, E.Cape
In Madwaleni Hospital, I spent most of my time with the HIV/AIDS team. I
observed a morning meeting with the HIV/AIDS team, comprising Dr Richard Cooke,
ARV clinician; Lynne Wilkinson, site administrator; Christina Kopana and Busiswa Joya,
peer educators; sisters at the hospital, and community health workers. I spent time
shadowing one of the peer educators, Christina Kopana in a satellite clinic visit, an
adherence counsellor, Anemari Buitendach during clinic day at Madwaleni, and also
followed Christina on her ward rounds to hand out pamphlets and conduct impromptu
education sessions in wards and waiting rooms. I also observed the proceedings of World
Aids Day at Madwaleni Hospital.
Other than observing, I spoke informally to Christina and Busiswa on the topic of
support groups and their role in treatment, stigma in communities, and adherence and
education sessions about HIV/AIDS. I also spoke to Lynne during an information session
about stigma in communities.
6

Literature Review

In my discussion of the primary healthcare model and its applications to ARV
care, I refer to the article, Can health promotion and primary healthcare achieve Health
for All without a return to their more radical agenda?, by Frances Baum and David
Sanders (1995). This article provides an in-depth discussion of strategies of “health
promotion” and “behaviour change”—ostensibly part of a primary healthcare agenda—in
fact fail to conceptualise healthcare in a way that allows it to address problems of
poverty, deprivation, and disempowerment. Primary healthcare in the era of HIV/AIDS:
Some implications for health systems reform by Petersen & Swartz provides a more
theoretical framework to understand the subversion of

“expert” power and patient

empowerment in HIV/AIDS treatment.
There is a wealth of research on community-based healthcare and activism around
HIV/AIDS in the developing world, including From Directly Observed Therapy to
Accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and Boston by H.L.
Behforouz, P.E. Farmer, and J.S. Mukherjee (CID supplement 5, 2004:38); and
Community-based approaches to HIV treatment in resource-poor settings by Farmer P, et
al (Lancet 2001; 358: 404-9). Specific to South Africa, Outcomes after two years of
providing antiretroviral treatment in Khayelitsha by Coetzee, D., et al provides an insight
into the clinical aspects of the first ARV rollout site in South Africa; The Impact of ARV
Provision on HIV/AIDS Prevention by Jo Stein (AIDS Bulletin, March 2005); Building
‘AIDS-competent communities’ by Catherine Campbell, Yugi Nair, Sbongile Maimane
and Zweni Sibiya (AIDS Bulletin, September 2005). These articles examine the role of
community support structures—including community health workers, support groups and
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faith-based organizations—in ARV treatment. The Impact of ARV Provision on
HIV/AIDS Prevention in particular focuses on the potential for the effects of treatment to
spill over into prevention efforts, for example in lessening stigma around HIV/AIDS,
encouraging testing, etc.
Two fascinating articles on the history of patient-led activism in South Africa can
be found in the volume Democratising Development: The Politics of Socio-Economic
Rights in South Africa (Jones P & Stokke K eds, 2005). The first, Shaping, Making and
Breaking the Law in the Campaign for a National HIV/AIDS Treatment Plan by Mark
Heywood (2005) tracks the strategies of the Treatment Action Campaign (TAC) to situate
the language of HIV/AIDS struggle in human rights discourse. The second, The TAC and
the History of Rights-Based, Patient-Driven HIV/AIDS Activism in South Africa by
Mandisa Mbali (2005) describes the roots of “patient activism” and the effects of the
TAC’s “campaign for openness” in the early 1990s.
Last but certainly not least, for critiques of market-driven healthcare and concepts
of “sustainability” and “cost-effectiveness” as philosophically flawed arguments that
prolong suffering in the developing world, refer to Pathologies of Power: Health, Human
Rights, and the New War on the Poor by Paul Farmer (2005) as well as Against Global
Apartheid by Patrick Bond (2001).
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Limitations of Study
This study was first of all limited by time. Spending 4-5 days in each site gave me
time to speak to several people involved in HIV/AIDS care, but often did not give me the
opportunity to observe their general routine and their work with others. A longer time in
communities would also have given me the opportunity to gain a better sense of the
communities in which I was researching.
In the study, most of the people I cite either work in the field of health, or are
positive people who have been trained to play a support role in ARV treatment. I consider
it a great honour to have met them and heard their insights. For a project that repeatedly
emphasizes patient-centred healthcare, however, I did not manage access to patients who
were not also in the position of activist, support group leader, counselor, peer educator…
I was also constrained in this respect by the language barrier, since many patients did not
speak English.
As a perhaps overly-optimistic study on the positive impact of ART, this report
perhaps concentrates on better- developed ARV programmes that do not reflect the state
of ART provision in South Africa. It could also consider in greater depth the modes of
delivery and evaluate the impact of ART accordingly. In other words, the existence of
education does not mean education is effective; and existence of counseling does not
mean that patients are necessarily changing their behaviour.
Lastly, ARV treatment is relatively new to South Africa, and a study of its impact
may be premature. More importantly, this study essentially examines the growth of
personal agency through a model of healthcare provision. While this looks optimistic, the
initial positive impact on small groups of people living with HIV/AIDS may be diffused
as programmes are scaled up and become more impersonal.
9

Introduction

Since the inception of the South African National AIDS Plan in 1994, it has been
accepted, in theory at least, that HIV/ARV care should exist within a primary healthcare
system. The National AIDS Plan prioritized not simply medical care, but also education,
prevention, counselling, human rights, welfare and research. (Marais, 2000)
Unfortunately, implementation of the National AIDS Plan failed to materialize, and
AIDS care was further jeopardized in the late 1990s and early 2000s by suspicion of
antiretroviral therapy (ART) and arguments that alleviating poverty should be prioritized
over HIV/AIDS care (Mbeki, 2003). Others argued that one cannot expect poor,
uneducated populations to stay on lifelong drug regimens requiring >95% adherence—
certainly, the developed world has not done spectacularly on that count either.
More fatally, arguments against ARV treatment (including the prevention of
mother-to-child transmission) subscribe to market-influenced conceptions of medical
care, which employ cost-effectiveness and sustainability assessments in decision-making.
Joia Mukherjee, a physician with Partners in Health, points out the contradictions of this
framework, and its failure to serve those in resource-constrained settings:

“The first (argument)… is that ‘we have limited resources, can we figure
out what gives us the biggest bang for the buck?’ That is the ‘small pie’ argument.
The second big argument is ‘even if you had all the money in the world, the
infrastructure is lacking so you cannot just throw money at a problem.’”
(Interview in AIDS Bulletin, September 2005)
This represented a philosophical shift away from the primary healthcare model, in which,
as Baum and Sanders put it, "considerations of equity, intersectorality and community
involvement were dismissed in favour of technical feasibility and cost-effectiveness of
programs." (1995)
10

It was further suggested that providing a complex drug adherence requiring strict
adherence to poor and largely uneducated peri-urban and rural populations would be
virtually impossible. (Interview with Hermann Reuter, AIDS Bulletin, March 2005)
Thus, when Medecins Sans Frontiers (MSF) set up the first ARV clinic in South Africa in
1999, in the township of Khayelitsha just outside Cape Town, there was a great deal of
skepticism as to its viability. Six years later, management of the Khayelitsha clinics has
been largely transferred to the provincial government. A new MSF pilot project in
Lusikisiki, in the rural Eastern Cape, recently enrolled its 1000th patient onto ART.
Adherence rates in Khayelitsha stand at approximately 70%, far higher than rates in
Europe and North America, which stand at approximately 40%. 1
The notion that complex drug regimens can be understood and adhered to in areas
like Khayelitsha and Lusikisiki has deeply jolted the assumption that the poor sick are
unsuitable candidates for ART. More crucially, it has resurrected the focus on primary
healthcare as a philosophy for HIV/ARV care by showing how healthcare can be
delivered in a viable, “sustainable“ fashion in resource-poor communities.
In delivering HIV/ARV care in the peri-urban and rural communities of
Khayelitsha and Lusikisiki, MSF marshalled forces within the community, involving
counselling, support group participation, and community health workers in the treatment
programmes. In particular, the Treatment Action Campaign (TAC) provided volunteers,
treatment literacy educators and lay counselors in support of the MSF effort. The TAC
also played an important role by encouraging disclosure and organizing patient-led
campaigns and movements.
MSF’s success in forming partnerships within the community to deliver quality
1

Statistics provided by Gilles van Cutsem, MSF, Khayelitsha
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ARV treatment demonstrates the notion that how treatment is delivered should receive
equal attention as the fact that treatment is provided at all. This question becomes
especially crucial in an epidemic so strongly associated with intimate questions of sex,
shame, and death, as well as with social issues of ignorance, stigma, gender inequality,
and poverty. By incorporating support groups, disclosure counselling, and education into
ARV programmes, these programmes acknowledge the responsibility of public health
towards both the sick and towards understanding the social context of sickness. Within
this framework, treatment becomes an opportunity for personal empowerment and social
transformation.
In this study I focus on the empowering nature of ARV care in resourceconstrained settings, drawing from examples of treatment sites in Khayelitsha in the
Western Cape, Madwaleni Hospital in the Eastern Cape, and in the Edendale community
in KwaZulu-Natal. I examine how patient empowerment takes place through learneroriented education, adherence and disclosure counselling, and through the privileging of
the patient’s subjective experiences of sickness in support group settings; and
demonstrate the ways in which the primary healthcare approach of these ARV
programmes has created the "empowered patient"—one who is knowledgeable, articulate,
and motivated to effect change in his/her personal life and the social conditions under
which he/she lives. Finally, I consider the ways in which the philosophical underpinnings
of these HIV/ARV programmes creates opportunities for South Africa to reconceptualise
primary healthcare to not only provide access to care for all, but also to act as a change
agent within communities.
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I. Patient-Centered Education : Treating the patient as a learner
ARV treatment, as my host Molly Kubheka put it, turns AIDS from a “death
sentence” into a “life sentence”. The rigidity and complexity of the drug regimen,
combined with the need for high adherence rates (>95%) to prevent resistance, present a
huge challenge to any patient—and not least, patients who struggle under conditions of
poverty and deprivation. Because of this, the consensus on several fronts has been that
adequate preparation is needed before a patient can go on ART. Patient education was
taken extremely seriously in both the BroadReach site in Edendale, and at Madwaleni
Hospital. In this section I describe my observations in adherence training and counseling
sessions in both sites, and suggest that the reorientation of health education to engage and
involve patients contributes greatly to the process of patient empowerment through
treatment.

Observations at BRHC adherence training
The team from BRHC conducted an adherence training session that lasted three
full days (8.30am-4pm) for the 50 new patients enrolled on the ARV program, and their
treatment buddies. The sessions were conducted in isiZulu and translated for me in part
by Nokothula Biyela, a Siyaphila support group leader. I was present for the first two
days and half of the third day.
Despite the large audience, the training sessions were highly interactive. Zanele,
BRHC’s Information, Education and Communications (IEC) coordinator, led the session.
She opened the session by asking what expectations the patients and buddies had of
BroadReach, of ART, and HIV. A wide range of statements and questions were supplied,
including: What happens if you stop ARVs after 2 months and start again? What changes
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will appear in my body after ARVs? How do I look after my nutrition and diet? How do I
encourage my partner to go for a test? These questions were written down on large pieces
of paper and put up on a wall inside the room. Zanele promised to address all questions in
the next three days. She then gave a short introduction to BroadReach, framing the
treatment program as a partnership in which BRHC, the support groups, and the patients
had equal responsibility.
The first day of the training session focused on introducing patients to the
program, and educating them on HIV/AIDS, how the virus works in the body, modes of
transmission, and opportunistic infections. The group was shown a series of pictures and
asked to form a story around them. In the first picture, a woman was shown walking
alone down a road in a village. The group named the woman “Katiwe”. Some suggested
that she was going to visit a friend, and others that she was beginning a journey. The next
picture showed two women sitting outside a house, and the group suggested that Katiwe
was disclosing her status to a friend. Zanele then asked the group: now that you have seen
where and how Katiwe lives, how do you think she got the virus? There was a range of
answers; some said that she had been caring for a sick HIV patient and was exposed to
blood, while others said that her husband works in a mine in Johannesburg and infected
her with the virus.
This became a discussion on how HIV is transmitted. Attendees were asked to
suggest other ways in which you could get HIV, besides unprotected sex. (Ideas included
sharing toothbrushes, being pricked by needles, blood on toilet seats, etc) Each idea was
discussed by the group and finally rejected or accepted. The group went through a series
of pictures in this fashion, and ended (for the day) with Katiwe in the doctor’s office.
For the second half of the day, the group was educated on how the HIV virus
14

works inside the body. The analogy of the CD4 “soldier” was used to explain what the
CD4 count meant, and also the processes by which the virus multiplies inside the body.
The second day of training focused on adherence and ARVs. Zanele opened the
session with a discussion of the English word “adhere” and “adherence”, asking the
group about what they associated with the words. The idea of “itape” was mooted and
discussed briefly, as well as the idea of “sticking to the rules”. Around the issue of
adherence, Zanele facilitated discussions on disclosure and the importance of disclosure,
support groups, and explained the need for “triple therapy”.
I attended the second half of the third day, after a focus group session with the
BRHC team. The third day consisted of role-plays put up by the facilitators from the
support groups, and large group discussions where the whole group sat in a large circle.
Later the group broke into four smaller groups, where they reviewed the information they
had received over the past two and a half days, and presented it to the group.

Observations at Madwaleni Hospital adherence counselling
In Madwaleni Hospital, I had the opportunity to sit with Anemari Buitendach and
her assistant/ interpreter, Zameka Ntibane, for a day of adherence counseling and followups. Anemari is a pharmacist by training and is in charge of issuing pills to both new and
old patients every month.
Before each existing patient could get a new supply of ARVs, he/she had a 15-20
minute conversation with Anemari about his/her experience of the past few months.
Besides asking about side effects, Anemari concentrated on two aspects regarding
adherence. She typically asked every patient what he/she was doing to ensure adherence.
Some patients said they set watch alarms, while others timed their medicines by events in
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the day—one man said he would wake up, take his medicines, then let the cows out; and
at the end of the day, herd the cows back in, and take his second dosage. Secondly, she
was concerned about the hospital-provided “treatment diary” and the “treatment buddy”,
and whether these were helping the patient. Almost all the treatment diaries I saw that
day were neatly filled in, and patients acknowledged that these forms were useful. Most
also agreed that the treatment buddy was helping, especially if the buddy was part of the
family and lived in the same house.
The general sentiment in these sessions was that the ARVs were “very right
kakhulu”. Patients enjoyed sharing their stories and reporting successes, such as weight
gain or re-commencement of work. Patients also reported being constantly hungry.
I also observed an hour-long “training” session that patients have to attend, on a
one-on-one basis with Anemari, before they are given their first month’s supply of
ARVs. The patients—a married couple—seemed to already know a great deal about
ARV care. They could report the names of their medicines (3TC, D4T, efivirenz for the
husband, and nevirapine for the wife), and could demonstrate the order in which drugs
should be taken (2 in the morning, and 3 in the evening. The wife also appeared to be
familiar with the side effects of nevirapine on the liver. Anemari further explained the
effects of ARVs on the virus, and the importance of adherence.
The second half of the session focused more on practical measures that would aid
adherence. The couple was asked where they would put their ARVs and if they would be
easily visible. They also were taught how to fill their own pillboxes, and how to use the
pillboxes and the treatment diary. There was a small struggle with relating the English
initials on the pillboxes to the days of the week in isiXhosa, and how the compartments
of the pillboxes worked.
16

I spoke to Anemari later on the protocol the hospital uses for adherence training
and her personal philosophy towards it. She emphasized the need to “not treat an adult
like a child”, and to help patients become responsible for their own treatment. She also
noted the importance of support groups as another source of information, where positive
people on ARV treatment can talk about methods of adherence and act as a source of
inspiration and encouragement for each other.

Interactive education as a form of empowerment
Adherence training is unique to the developing world, driven primarily by a need
to prevent drug resistance in the two drug regimens supplied in South Africa. Marcus
McGilvray, IEC coordinator of BRHC, pointed out that the very existence of “adherence
training” is a new concept that is significant in itself. (21/11/05) The impetus for
developing education programmes for patients came from the high dropout rates from TB
treatment programmes, even where directly observed therapy was utilized. ARV care
thus took lessons from the failure of TB care in designing a more patient-centred
approach to treatment delivery.
Because there is no precedent to “adherence training” in the developed world,
adherence training programmes in South Africa and the developing world were designed
on an “ad-hoc” basis. BroadReach Healthcare’s training model draws upon “the culture
of storytelling, which is typical to African culture.” (06/12/05) Thus several of the
exercises, as described above, involve forming narratives around HIV/AIDS and drawing
lessons from them—for example, the picture exercise, and the analogy of the CD4 cell as
“soldier.” Marcus suggested that, although little research has been done on the topic, it
seems the more patients understand about HIV, side effects, and resistance, the more
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likely they are to adhere to drug regimens. “It’s essentially active learning,” he
commented, noting that a great deal of research has been done on topics such as learner
involvement in education. (06/12/05)
However, Marcus pointed out several areas of the BRHC model that need to be
further developed. The lack of one-to-one counseling by qualified counselors, for
example, makes it close to impossible to find out what stage an individual is at in terms
of psychological well-being and behavioural change. The cycle of first accepting one’s
status or condition and then changing one’s behaviour is necessarily disrupted or restarted
by side effects of ARVs. Thus one-on-one consultations with trained counselors are an
imperative in ensuring drug adherence. (06/12/05)
The need to involve patients in learning around their own condition and treatment
has become essential in any model of ARV delivery. But implementation of educational
development theories are often constrained by factors ranging from a lack of personnel to
poor choice of venue. Fundmentally, the belief remains that patients must possess
understanding ways that they previously did not, with TB-DOTS, for example. Yet, the
effectiveness of education is intricately linked with a need to understand and monitor the
psychological condition of the patient. In the following section, I discuss the role of
counselling and support groups in treatment, and the process by which patients come to
accept their condition and develop a sense of community around being HIV positive.
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II. Linking the medical and the psychosocial: Promoting openness and dialogue
about AIDS

The condition of disclosure
In both programs I visited, disclosure was a prerequisite to the commencement of
ART. The patient is encouraged to first disclose his/her status to at least one more person,
with the dual assumption that 1) this person can become a treatment “buddy” or at least
provide frequent reminders to the patient and 2) that a patient who has not disclosed
his/her status still struggles to accept his/her status, and therefore is not yet the best
candidate for lifelong ART.
The link between disclosure and adherence places unprecedented import on the
psychosocial experience of the patient in medical treatment. It recognizes a link between
the psychological and the physical experience of illness—that stigma within the
community can impact a patient’s ability to adhere to treatment. This cuts a contrast to
conceptions of compliance that rely on physicians’ assessment of “social worthiness”
(e.g. alcoholism, inclination to violence) or educational status. (Farmer, 2005; Stein, et al,
2005) Furthermore, the emphasis on disclosure as a precondition to treatment creates a
necessary journey that patients must make—towards accepting their own condition and
finding pride in their personal act of disclosure.
In Edendale, I asked several support group leaders about conditions promoting
adherence. My question was met with virtually the same answer each time: that people
default on ARV treatment because they had not come to terms with their positive status.
Sipho Mncwabe, the chairperson of support group Sbongukuphila in Edendale, said:

“Sometimes people hide their pills from their family, they don’t put it in
19

the kitchen so they forget to take it, or the family will ask, ‘why are you taking
these pills?’ That’s why people must disclose… People are staying together in one
house but no communication, because they are scared to address their status.”
(24/11/05)
Molly Kubheka, founding member of Siyaphila, an umbrella support group for
groups in the Pietermaritzburg area, noted that there is a small minority of people who are
“just not committed”, but for the most part, people don’t adhere because

“they are still hiding their status, they don’t dare to take their pills in front
of their family.” (24/11/05)
Similar sentiments were echoed at Madwaleni Hospital. During a morning
meeting for the HIV/ARV team, a support group leader suggested that using disclosure as
a prerequisite to treatment might constitute a form of discrimination, or violation of rights
on the part of the patient. Several of those present at the meeting disagreed with the
statement, insisting that adherence to ARVs was impossible if treatment was taken in
secret. Busiswa argued that lifelong treatment cannot be a solo effort.

“Sometimes I even forget to take the ARVs, and my mother will remind
me, or my family will remind me. So I think if you say you don’t have to tell
anyone, and you can do it by yourself, it is not like that.” (28/11/05)
Lynne Wilkinson, site administrator for the ARV program, noted that
“No one has ever refused a treatment buddy on the grounds that they feel
completely competent… Mostly it is because they are afraid to disclose their
status.” (28/11/05)
In general there was a great concern for the patient’s psychological condition and
the effect this would have on successful treatment. Healthcare workers and counselors
saw the act of disclosure as an empowering act, signifying personal reconciliation with
the illness. Christina Kopana, a peer educator at Madwaleni Hospital, described the
support they provide to patients regarding disclosure.
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“We ask them to draw a family tree… then we see, who is suitable for the
patient to tell. If they draw a tree and the father is an alcoholic, or the mother left
the patient years ago, we don’t advise them to disclose to them. We find the best
person and teach them how to disclose.” (30/11/05)
Busiswa, another peer educator, herself HIV positive, said that people now “feel
bold, and can go home and disclose.” Further, in this process, counselors find themselves
becoming more involved with the social and personal aspects of patients’ lives. Busiswa
recalled an incident after a support group meeting where a woman realized that her
husband who works in Johannesburg must have infected her:

“She said she wanted to call her husband in Jo’burg and scream at him,
‘how can you sleep around and give me AIDS?’ So I had to say, no, that is not
how you should do it, you must wait for him to come home and talk about it.”
(28/11/05)
Furthermore, it has been argued that the act of disclosure signifies more than an
acceptance of one’s medical condition and the determination to change it. It represents a
defiant exercise of individual agency despite the risk of discrimination, rejection and
exclusion. Mandisa Mbali writes,

“As the first few brave openly HIV positive AIDS activists stepped
forward, it showed that the right to confidentiality did not have to mean enforced
secrecy, nor did people living with HIV have to give all their power to the doctors
treating them; they had the right to either hide or reveal their HIV status, showing
their agency in forming strategies and tactics to resist AIDS-related
discrimination.” (2005)
In this sense, disclosure becomes an act of self-definition and empowerment. The
condition of disclosure then signifies a renewed emphasis on the patient’s psychosocial
condition in successful treatment. Inside this framework, it becomes possible to subvert
the power of “experts” to predict categorically whether a patient can or cannot be
compliant— an exercise long considered largely fruitless (Farmer, P. et al, 2004). The
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patient is seen as a human being who can be empowered to act under social constraints,
which are themselves changeable through public health measures. Healthcare workers
invariably become more involved in patients’ social realities and their personal journeys
towards acceptance and disclosure. The healthcare sector thus takes on a new role of
empowerment, one that is deeply embedded in social transformation.

“It’s not just me, now it’s us”
The task of ARV programmes to provide psychosocial support so as to ensure
adherence, as I discussed in the previous section, has resulted in an expansion of
networks surrounding the sick. There is an increasing awareness of the need to tend to the
sick and the experience of sickness outside the doctor’s office. (Brouard, 2005) Thus,
support groups, which provide a space for patients to discuss their HIV status and also
their experience with ARVs, have become a central part of many ARV programs. Molly
put it this way:

“The doctor will only see you for a few minutes, but the support group is
always there.” (24/11/05)
The support group establishes a dialogue among patients where patients can learn from
each other and derive encouragement from shared experience. Referring to her
community in the township of Imbali, Edendale, Molly stressed the importance of
structures of support to the sick. She pointed out the frustration that positive people feel
about their status and the “life sentence” of ART, as well as the need to provide a space
to talk about negative and positive experiences alike.

“Some days I just look at the pills and push them into my mouth, I’m so
cross about taking the pills… Sometimes you see people coming out of the clinic
and their test results are negative, and you think, ‘why me? What did I do?’ But
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with the support group, it’s not just ‘me’, now it’s ‘us’, that’s why support groups
are so important.” (24/11/05)
The social capital that grows out of knowledgeable and empowered patients, able
to provide support to others, plays a huge role in ARV programmes. Anemari, the
pharmacist for the Madwaleni HIV/ARV programme, observed that ARV patients
themselves are themselves a great source of encouragement and support to newer
patients, and make a great contribution to the rollout process. (29/11/05) This is what
Farmer (2004) refers to as the “virtuous social cycle” that arises out of treatment
programs, where “neighbours are enlisted in the struggle against tuberculosis and HIV
infection.”
Where the function of the medical doctor shrinks into a larger system including
support networks, counselling and education, healthcare can begin its descent from the
arena of “expert” knowledge and engage patients on the layperson’s level. Gilles van
Cutsem, a doctor at the Khayelitsha Site C clinic, noted that the ARV programme run
jointly by Medecins Sans Frontiers and the Western Cape province uses lay counselors,
treatment literacy educators, and support groups help to demystify potentially confusing
medical explanations. Gilles observes,

“The language the doctor uses is rarely appropriate... We rely a lot on the
counselors to transmit information and explain things to patients.” (16/11/05)
Furthermore, advice given by support group members has the benefit of personal
experience, which can often be comforting and encouraging as well. Gilles commented,
describing the crucial role of support groups in ARV programs,

“If the patient comes to you with a rash, you can say oh it’s normal, it will
go away… but in the support group, someone will say, I understand, that
happened to me two months ago, its normal… sometimes that is more effective
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than the doctor.” (16/11/05)
I observed two support group meetings during my time at Madwaleni Hospital.
The first took place at the hospital itself, and comprised mostly patients who were being
prepared for ARV treatment. I struggled to follow the session with my thin understanding
of Xhosa, but was able to get a general sense of the proceedings. Sister Willie from the
HIV/ARV team led the session. All the new faces in the room—myself included—
introduced themselves, and were welcomed by Sister Willie. This was followed by short
introductions from some of the older members of the support group, one or two of whom
had already started ART. For the next hour or so, Sister Willie led a conversation with the
group, addressing individuals and answering questions about ART. Lynne Wilkinson, the
site administrator for the Madwaleni HIV/ARV programme, later commented that one
probably did not need to understand Xhosa to get a sense of how the support group
operated—it was apparent from the Sister’s tone of voice, her encouragement of the
quieter members of the group, and the evident engagement of majority of people in the
room—despite frequent interruptions by crying babies and ringing cellphones.
The second support group meeting I attended took place in Nkanye clinic, about
40 minutes away from Madwaleni. This was a smaller support group for both patients
already on ART and those being prepared for ART. At the start of the session, members
stood up and introduced themselves, and stated the date on which they began ART. One
of the sisters of the clinic led the session. A lively and informal discussion ensued,
apparently sparked off by one member’s description of the rash he got from the ARVs.
As new members filed in, they were welcomed warmly with songs. Most striking in the
Nkanye session was the use of music to convey messages about HIV and ARV. One song
roughly translates to, “Me, I have tested for HIV/AIDS, have you?” Another one
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appeared to be a call to treatment, and involved complex medical terms such as
“cryptococcal meningitis”, “fluconozale”, and “nevirapine”.
The familiarity of all the support group members with terms that other nonmedical people routinely trip over only emphasized the notion that the poor, uneducated
sick can indeed attain extensive knowledge about their medical condition. This
phenomenon is not unusual: it has been observed from Lusikisiki in the Eastern Cape, to
Cange, a slum area in Haiti (Farmer, 2005):

“(in Lusikisiki) Before long, people… were donning HIV-POSITIVE Tshirts, singing about the virtue of condoms and quizzing each other on the
difference between a nucleoside-analogue reverse transcriptase inhibitor and a
non-nucleoside-analogue reverse transcriptase inhibitor.” (Newsweek,
19/04/2004)
The role of support groups in ARV treatment cannot be overemphasized. Because
of the psychological support and education received in preparation for ARVs, patients on
treatment are mentally and physically more empowered than other members of the
community. They have more knowledge about healthcare and nutrition, are familiar with
the biomedical processes of the virus and complex drug names; most of all, having
trodden the difficult path of personal acceptance, disclosure and finally treatment, they
are in the best position to give advice to other positive people.
It is perhaps difficult to grasp the magnitude of empowerment that takes place
when positive people come to play an equally important role—some argue, a more
involved role—in treatment than healthcare professionals themselves. It has been argued
that the ability of the support group structure to build confidence in more withdrawn
members contributes significantly to the empowering effect of ARV treatment. It
certainly takes courage to speak about one’s own condition in front of a group of at least
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twenty individuals. As a result, many of the HIV positive people in Madwaleni and
Edendale were extremely articulate about their own condition, and came to play an
increasingly visible role in awareness-building, prevention, and treatment activism.
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III. “Amandla Ngawethu”: Patient-centered Activism
On World Aids Day, all the support groups from the clinics on the Madwaleni
HIV/ARV program came together in the church at Madwaleni Hospital. Support group
members sat in the church waiting for the program to begin, as gospel music and songs
about HIV/AIDS played on the sound system. Then a recording of a rally for treatment
came on, declaring “Amandla!” The support group members sitting in the pews raised
their fists and chanted, together with the recording, “Ngawethu!” “Amandla!”
“Ngawethu!” 2
This spectacle represented to me the power of positive people themselves to effect
change in their communities—to demand treatment, to educate others against stigma and
ignorance, and raise awareness about prevention. In both Edendale and Madwaleni,
support groups comprising positive people, many receiving treatment, formed the
backbone of movements within communities to educate their communities, and to
reclaim the right to be respected as a healthy and normal member of their communities.
In this section I draw a link between patient empowerment through treatment as
discussed in the previous section—where patients are educated and counseled so that they
can take responsibility for treatment—and patient “activism”, where positive people
stand at the forefront of efforts to halt the spread of the epidemic.

The unwitting activist: Impact of ART on perceptions of HIV
It has been suggested that the fact of treatment can be a mode of activism in itself,
where the visible effect of ARVs to “literally resuscitate people” lessens collective

2

“Amandla Ngawethu” translates to “the power is ours”. This chant was often used during anti-apartheid
protests. Its use today situates the struggle for the rights of people living with HIV/AIDS as analogous to
the struggle of the 80s: militant, unrelenting, and proud. See Mbali, 2005
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suspicion towards the disease and also towards positive people. (Gilles van Cutsem,
16/11/105) Echoing Paul Farmer’s assertion that “if care is available, stigma goes away”,
Gilles van Cutsem from the Khayelitsha Site C clinic held that the availability of
treatment has increased the willingness of people to test for HIV, and aided the
movement towards openness and disclosure. (AIDS Bulletin, June 2005)

“When we first started, stigma in the community was very large. HIV was
always seen as someone else’s disease. So everyone said, ‘nobody will come’ (to
the clinic)… In the first year, 1999, we had just over 100 people testing. Now we
have thousands testing a year.” (16/11/05)

During a focus group session with three members of the BroadReach team, I
asked if they had observed any changes in the communities in which they work as the
roll-out continues. The positive impact of ART was recognized emphatically by all
members. Bongani Nkosi, regional coordinator of Mpumalanga, described his
experiences in an unnamed community where stigma was very high. He recalled their
modest expectations at the start of the BRHC intervention given the level of stigma in the
community, and compared it to the expected turnout at the upcoming enrolment:

“This time we are expecting about 150 patients, which is very big, we’ve
never seen those numbers before. And so I think treatment itself breaks down
stigma. People usually think HIV patients are very sick, cannot move, are dying,
but then they see that positive people can lead a normal life… And so I think over
time people will start to see HIV/AIDS as just another kind of disease.”
(23/11/2005)
Zandile Wanda, the regional coordinator for KwaZulu-Natal, agreed that there
was potential for change, but pointed out that societal stigma remained high. She cited the
local support group Siyaphila as an example of persistent ignorance and discrimination
against positive people. Members of Siyaphila hold support group sessions at a nearby
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“drop-in” center for hospice care; in the kitchen, they are not allowed to share silverware
with the rest of the center. She stressed that it will take a long time, and lots more
education in communities, for them to fully accept positive people. Still, the team
remained optimistic on most counts. They acknowledged that the mere sight of someone
coming with someone positive was a great thing, given the level of stigma “by
association”— as Bongani put it— that existed previously.
Indeed, it has been argued that because ARV provision decreases the perception
of HIV/AIDS as a “death sentence”, it is likely to decrease the fear around infection and
by extension stigmatisation of HIV-positive people. Stein (2005) argues that the fear of
infection does not in fact lead to safer sexual behaviour, but rather a continued rejection
and denial of the virus and of others infected by the virus.

“The logic of current psychological theories of AIDS denial and
stigmatisation strongly suggests that (the availability of ART) will result in
decreased denial and stigmatisation and in increased safer sexual behaviour, not
only among those who are infected, but in society at large.” (Stein, 2005)
By reducing the fear of infection and death, ART creates a beneficial spillover
effect in communities. In the heading to this section, I used the phrase “unwitting
activist”— in a very real sense, patients on ART exist as visible new symbols of AIDS in
individuals and communities. In no way is this meant to dismiss the personal and social
struggle for acceptance that the vast majority of AIDS patients necessarily experience
before commencing treatment. In the next section I turn to the idea of the patient activist,
a direct extension of the empowered patient, purposefully seizing upon his/her own new
physical and mental condition to play a larger role in the fight against HIV/AIDS.

29

Effecting change in communities: A task for empowered positive people
In both the communities of Madwaleni and Edendale, positive people were active
in treatment lobbies and educational campaigns. During the Madwaleni Hospital World
Aids Day event, the burden of responsibility on positive people to fight against
discrimination and for treatment was emphasized repeatedly. In Lynne Wilkinson’s
speech, she credited support groups for the success of the Madwaleni ARV program, and
reminded support group members of their responsibility to raise awareness in their
communities and to encourage people to test for HIV. Christina Kopana, speaking on her
experience as a person living with HIV/AIDS and as a support group leader, declared an
urgent need to fight discrimination against positive people. (World Aids Day Ceremony,
1/12/2005)
Many of the support group leaders I spoke to likewise expressed a sense of
responsibility towards educating their communities. Sipho of Sbongukuphila spoke of the
importance of eradicating ignorance towards HIV/AIDS as a crucial step towards
prevention as well as decreasing stigma in communities. Indeed, the general consensus
among respondents was that stigma was caused by ignorance more than any other reason.
I suggested to respondents that stigma could come from other factors, such as the
association of HIV/AIDS with immorality or promiscuity. In reply, they associated
HIV/AIDS stigma with fear (caused by ignorance) or superstition, rather than with moral
arguments:

“I have disclosed my status, everyone knows I am positive. And
sometimes people don’t dare to talk to me. They think if they touch my gate they
will also become HIV positive.” (Molly Kubheka, 21/11/05)
“They hear that the numbers are so high, that everyday more people are
getting infected, so they say you are wrong when you tell them that you can’t get
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HIV from just talking to me or holding my hand.” (Molly Kubheka, 24/11/05)
“The positive people and their buddies must go into the community and
talk to their neighbours, and spread the message. Then we can end the rumours
about the witch doctors.” (Sipho Mncwabe, 24/11/05)
“There was a woman who came in with her sister, who is positive, and she
was so worried about getting infected. After I explained to her that it’s okay to
share your cups and bowls, but just be careful about blood, she was so relieved
and happy. So we are working to fight that sort of ignorance.” (Anemari
Buitendach, 29/11/05)
“People have a lot of wrong information. When sometimes there are a mix
of people in my house, I try to hold some education, and tell people about
HIV/AIDS, how you can get infected.” (Zameka Ntibane, 29/11/05)

In the Madwaleni HIV/ARV programme, positive people—both those enrolled in
the programme, and those already on ARVs— are involved in the hospital campaign to
encourage testing. At support group meetings it is common to see positive people
wearing the badge that reads: “Ndilixilongile igazi le-HIV. Wena?” (I have had my blood
tested for HIV. Have you?) The hospital has formally hired two participants in the ARV
program as permanent staff. They work on an equal footing with community health
workers, the ARV clinician, the site coordinator, nurses and counselors. I spent a
morning with Christina, on ARVs since March, and now a permanent member of the
Madwaleni HIV/ARV team. Our task that morning was to go around to the wards and the
waiting rooms in the hospital with pamphlets, and encourage people to take the rapid test
for HIV.
As I suggested in the previous section, the existence of treatment has the potential
to increase the effectiveness of educational and awareness campaigns within
communities. However, the fact that positive people are taking it upon themselves to
educate their communities is a phenomenon that warrants further exploration.
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Why are so many positive people involved in HIV/AIDS activism? Positive
people on ARV programmes are acutely aware that they possess a wealth of knowledge
that remains inaccessible to many. They recognize that the AIDS epidemic is spiraling
out of control, and that government and international responses to the crisis have been
weak and incompetent. Their motivation for involvement thus emerges from a deep
understanding of the epidemic and empathy for those infected and affected by it. This
understanding is directly facilitated, even created, by the processes surrounding ARV
treatment. 3
The active involvement of positive people in HIV/AIDS activism speaks in direct
defiance of reductionist, flawed conceptions of “primary healthcare”, which situate the
patient as a static entity in relation to “health promotion” strategies, ignoring the agency
of the patient to influence the events that shape behaviour and decision-making:

“It suggests that the language (of flawed conceptions of primary
healthcare) may have the effect of making the people health promoters work with
passive actors who have no control over events: health promotion is something
that happens to them.” (Baum & Sanders, 1995)

Within this framework, patient-led activism is at bottom a declaration of patients’
abilities to make decisions about their own condition. This comes from the tradition of
the TAC’s “Campaign for Openness” in the early 1990s. (Mbali, 2005) The movement
instilled a sense of pride and self-respect in positive people, and gave them a public voice
in demanding the right to treatment and respect. Mbali writes,

“From a mere handful of openly HIV positive white gay activists in the
3

In my conversations with Molly, Christina and Busiswa, they constantly reminded me of the magnitude of
the epidemic, and the massive ignorance surrounding it. Christina in particular repeatedly declared, during
one of our conversations, “one out of four people in the Eastern Cape are HIV positive, and only a quarter
of them know it.”
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early 1990s, in the first years of the 21st century… TAC’s protests would come to
consist of a humn sea of thousands of HIV positive and HIV negative activists
wearing t-shirts proudly proclaiming “HIV POSITIVE.” (2005)

In 2003, Zackie Achmat declared that HIV positive people do not demand pity; they
demand rights. (Mbali, 2005) Thus our understanding of the movement by prominent
PLWAs within support groups to promote awareness and education on HIV/AIDS must
also be linked to their demand for rights—the right to remain a social participant in their
community despite illness, their right to be treated with respect and understanding, and
their right to lead fulfilling lives despite being infected with HIV. What treatment has
done, then, is provide the physical, psychological and intellectual support and agency
needed by positive people to organize and effectively demand these rights.
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IV. Beyond empowerment: reconceptualizing the role of public health in South
Africa

The paradigm of patient empowerment: Responsible for good health, not blamed for ill
health
I wish to suggest in this section that ARV treatment as it is currently
conceptualized provides an opportunity to interrogate the assumptions underlying current
healthcare systems, and rethink the role of public health in community development and
nation-building. The restructuring of healthcare systems is beyond the scope of this
paper, although there has been a great deal of scholarly research into the relationship
between ARV programmes and the primary healthcare framework. Here, I hope to
highlight the impact of treatment on the ways in which we conceptualize patient agency
and the potential for agency to translate into change. I also suggest that taking lessons
from ARV programmes requires a deeper understanding of the relationship between care
and agency, and agency and change.
There are several important ways in which aspects of current ART models
embody the philosophy of primary healthcare 4 . Firstly, it signifies a shift away from
“prevention-only“ that, by promoting “life-skills” and informed decision-making, ignore
the social context of decision-making. Implicitly, pure “prevention” strategies establish
the “responsibilisation” , or blame, of individuals for their own ill health. (Petersen &
Swartz, 2002)
In contrast, by seeking to understand and change social conditions impeding
successful treatment, the primary care model recognizes constraints on patients’ choices
and power in social situations. Furthermore, conceptualizing treatment as inextricably

4

A model long recognized to be moribund or an “experiment that failed”, despite good efforts to the
contrary. (Sanders & Werner, 1997)
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linked to prevention efforts recognizes deeper, more complex psychosocial factors that
influence perceptions of disease and reactions to education and information. Recognizing
the psychological logic of stigma and the effect of treatment on this “logic” is one case in
point; understanding patient adherence as a function of the patient’s own psychosocial
condition is yet another.
More significantly, by involving the patient and other support networks more
extensively in the treatment process, treatment implicitly subverts the power differential
that exists in the conventional doctor-patient relationship. Writing about this “unequal
power differential,” Petersen and Swartz note:

“This approach is reflective of the dominance of scientific rationality over
emotional and moral dimensions of illness. It is, however, antipathetic to the
notion of ‘empowerment’ which underpins health promotion and arguably the
success of psychological interventions.” (2002)
In ARV programmes, the subversion of “expert” medical power begins with and
takes place through the process of patient education, counselling, disclosure and finally
treatment. The involvement of HIV-positive people in established treatment programmes,
working side by side with healthcare workers and professionals, attests to the leveling of
that power. In patient-led activism, the subversion of medical power demands that the
voices of positive people are heard and respected within communities, in the public
sphere, and in policy-making surrounding HIV/AIDS. This is particularly important in
the HIV/AIDS epidemic, where the distribution of physical suffering correlates strongly
to distributions of poverty, gender inequality, and other experiences of social and
psychosocial suffering.
The move from a healthcare philosophy which places the blame of poor health on
individual belligerence and ignorance, to one which accords the individual the knowledge
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and support required for him/her to take responsibility for his/her own health, may seem
like little more than a play on words. Yet in terms of health policy and structures of
delivery, it makes a world of a difference. It may be that the latter model stands as the
only viable way by which healthcare—especially ARV care and treatment—can be
extended fairly successfully to the vast numbers of people who need it. 5

Taking lessons from ART: Exploring the meaning of “empowerment”
To truly take lessons from the ARV rollout to strengthen existing health systems
in South Africa, one must assess the fundamental assumptions underlying both existing
health systems, and successful ARV treatment models. As a part of a national health
system, HIV/ARV programmes constantly experience a tension between national health
policy and localised ARV treatment initiatives. Some have pointed out that the
government has yet to recognize the importance of support networks for the sick, thereby
systematically neglecting the well-being of those who provide the support—nurses,
home-based carers, community workers. (Stein et al, 2005) Others resist the “overmedicalization” of HIV/AIDS care and argue against the “attraction towards a ‘magic
bullet’ or technological solution” that shafts a multisectoral response to HIV/AIDS.
(Chopra, 2005)
At bottom, these critiques speak to fundamental differences between existing
localized ARV programmes, and the current governmental framework: differences in
how HIV/AIDS itself is conceptualized, and in how the person living with HIV/AIDS is
conceptualized in relation to the disease, his/her community, and to healthcare workers.
5

In my interview with Andrew Boulle, a doctor at the HIV/ARV clinic in Khayelitsha and a researcher at
the UCT medical school, he referred to this as a “revolution” in healthcare, noting that “you can’t police
people forever.” In this sense empowerment-based care appears to be the only way to provide a complex,
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Therefore, the acceptance that patient empowerment must needs sit at the centre of a
primary healthcare approach entails also a consideration of what empowerment means in
different settings: That is, how healthcare can and should marshall forces of individual
agency and community cohesion in improving health. The closely-knit, supportive
community does not form of its own accord; it is a result of a process of accepting
members of their community living with HIV/AIDS, understanding and learning more
about the disease, and finally taking personal and collective responsibility towards the
health of communities. Currently the TAC acts as the agent of organisation in several
communities; but the TAC as a grassroots organization—and one regarded by the
government as adversarial—lacks the wherewithal to reach the number of communities
and effect the level of change it desires. (Interview with Gilles van Cutsem, 16/11/05;
Interview with Andrew Boulle, 07/12/05) Taking lessons from the empowerment model
then necessitates the establishment of means of communication between the state and
community experience and activism, where communities can truly be given a voice and a
hand in improving healthcare and health education.
Building a stronger health system that integrates ARV care, then, requires more
than simply “reclaiming” in theory the focus of healthcare on the patient, and the
patient’s experience of disease; it requires a strong reevaluation of what empowerment
means and how it manifests itself in individuals and communities, and the new
responsibilities of the state to that empowerment.

lifelong regimen on a large scale without massive defaults or personnel deployment.
37

Recommendations for Further Study
In the course of this study, I spoke to numerous healthcare workers—be they
doctors, nurses, clinicians, counsellors, or educators. Most, if not all of them, attested to
the profound sense in which ARV treatment had radically transformed HIV/AIDS care,
their interactions with their patients, and their personal experience of caring for the sick.
At the same time, most of them—especially clinicians, nurses, and counsellors working
with populations that had poor access to health services or patients dealing with
discrimination from family members and neighbours—expressed a great sense of
frustration at the lack of resources and support they had on hand to help the sick in their
communities. A study that examined the impact of ART provision on healthcare workers
would not only shed light upon post-ART medical relationships, but also provide insight
into studies on scaling up ART and strengthening the primary care framework.
Another interesting area of study is the role of traditional healers in HIV/AIDS
care. In my conversation with Marcus McGilvray from BRHC, he pointed out that in
general, when people in rural communities get sick, the first person they visit is their
neighbour or close family. The second person they visit is the sangoma, traditional
healer. Yet little or no efforts have been made to educate traditional healers about ARV
treatment and HIV/AIDS care in general, due to the power embedded in that crosscultural interaction. More broadly, this phenomenon suggests that a study into
information networks around the sick and the social and cultural processes by which
behavioural decision-making takes place.
Other ways of furthering this particular study could include a focus on stigma in
communities and a study of the logic and nature of that stigma.

A study of the

effectiveness of training and counseling methods for HIV-positive people in resource38

poor settings would inform many of the observations and inferences made in this paper.
Lastly, a study of patient-led activism and the impact of that form of activism on
conceptualizing and achieving the right to health would provide great insight into theories
of rural resistance and of social movements. This study might also examine the role of
treatment and patient-led activism in strengthening political sensibilities in rural/ periurban areas, as well as democratic institutions as a whole.
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Conclusion

In this study, I have explored patient participant in an ARV programme as a
journey of empowerment—through education, the building of self-respect and
confidence, psychological acceptance and physical strengthening, and finally a
heightened awareness of one’s voice and one’s agency in using that voice to demand and
persuade change. Clinicians, community health workers, and counsellors alike have
spoken to me of the spectacular impact ARV treatment has had on their patients, both
physically and psychologically; as well as on stigma and discrimination in communities.
As I noted in my recommendations for further study, the task ahead remains daunting.
Numerous questions remain—largely revolving around how to scale up antiretroviral
therapy in South Africa, and how to integrate ART into the national healthcare
framework. Much of this work will involve systems research and planning, as well as
economic and human resource evaluation. However, underlying healthcare reform must
be a rethinking of the concept of “health”, and by extension a rethinking of how the sick
are structurally defined in healthcare systems.
The notion that patient empowerment contributes tremendously to the success of
ARV programmes, and has positive spillover effects for the community at large, suggests
that we should no longer consider the viability of healthcare systems to be contingent
upon theoretical models of “cost-effectiveness” or “sustainability”, which treat the patient
as a static, passive recipient of healthcare. (Petersen & Swartz, 2002) To the contrary, if
the patient is considered as a partner in healthcare who can be empowered, public health
can reclaim its original goal of improving the health of communities as a whole—by
treating ill health, the conditions that perpetuate ill health and, correspondingly physical,
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psychological and social suffering caused by ill health. (Petersen & Swartz, 2002) Still
others suggest that there is no other viable way of providing healthcare, especially ARV
treatment, to large numbers of people if they cannot take responsibility
Even after we accept that patient empowerment must be the underlying
philosophy to building a strong primary healthcare model, the how of empowerment
proves even more complex than the why. ARV treatment is still extremely young in
South Africa, and the number of people on treatment is but a small fraction of those who
require treatment presently, and will require treatment in the following years. Those who
do manage to navigate the difficulties of their environment to enroll in an ARV
programme appear to have done exceedingly well; less is known about those who have
not. We know that patients can be empowered; the next challenge is how to best educate
and counsel the far larger numbers of people who thus far have not navigated through to
highly inaccessible services to obtain treatment. (Interview with Andrew Boulle,
07/12/05)
The potential for a strong ideological association between healthcare delivery and
social transformation has implications not only for the nature of healthcare reforms, but
also developmental strategies in the new South Africa. The lack of political will has been
frequently raised as the root of the sauntering progress of ARV roll-out in South Africa.
Stronger state commitment to the social role of healthcare could create opportunities for
education and access that grassroots social movements—even well-organized, deeply
influential movements like the Treatment Action Campaign—cannot create for
themselves. Even in Khayelitsha, where the TAC is arguably the most active, messages
have not broken through completely; a sizeable amount of people still do not know what
the TAC stands for. (Interview with Andrew Boulle, 07/12/05) The use of state-owned
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media to remind patients to take their medications is an example of what stronger state
commitment can achieve; having political leaders speak up about their status is another
case in point. (Interview with Herman Reuter, AIDS Bulletin, March 2005; Interview
with Andrew Boulle, 07/12/05)
Finally, recognising the responsibilities of public health necessitates the linking of
public health to other spheres of social experience (or social suffering). It requires an
awareness of other modern day struggles—for land, housing, access to education, and
privatization of public service, to name a few. As Joia Mukherjee puts it, “as physicians
we should also be activists against the policies that we know are hurting our patients.”
(Interview with AIDS Bulletin, September 2005) But the physican activist— or for that
matter, the health activist of any form—can only do so much in situations of extreme
resource deprivation and lack of support. 6 In the final analysis, only the “synergy
between state response and community activism” can effect changes in the healthcare
system that generate positive effects in the communities that either labours to serve. 7

6

There are of course strategies of mobilization and legal activism that have in the past been extremely
effective. The TAC’s lawsuit and civil disobedience campaign against the state arguably led to the
government’s recent commitment to an ARV rollout. It may be less feasible, however, to suggest that
grassroots activism in local community settings – especially settings of resource constraint—can have the
influence or impact that the TAC does in its urban, intellectual-led movement.
7
In my interview with Andrew Boulle, he used the phrase “synergy between state response and community
activism” in reference to the missed opportunity—due to government intransigience and AIDS denialism—
to fight the AIDS pandemic both from the top down and the ground up.
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Appendix: Interview Questions
Informal Interviews with support group leaders/ community health workers, 20/11/051/12/05
(Molly Kubheka, Nokuthula Biyela, Sipho Mncwabe, Christina Kopana, Busiswa Joya,
Zameka Ntibane)
In my time in Edendale and Madwaleni I had the chance to interact on a day-today basis for four or five days with the healthcare workers. Often informal interviews
took place in between patients in counselling rooms, or on trips to the clinic. In these
interviews I did not ask a specific set of questions, but directed the conversation to a few
areas of interest.
Topics raised:
- Adherence—How difficult is it to establish adherence, and why do people default
on life-saving treatment?
- Disclosure—how do you help people to disclose their status? Why is this so
important for treatment?
- How do you see your role as a support group leader/ community health worker in
the fight against HIV/AIDS?
- What do you think should be done to reduce stigma in your community?
- How has your experience as a support group leader/ community health worker
changed after ARVs are available?
- Why are support groups so important in ARV treatment? How much time is spent
in support groups?
Informal Interview with Lynne Wilkinson, site administrator for Madwaleni HIV/ARV
programme, 28/11/05
-

What are the different aspects of the HIV/ARV programme at Madwaleni?
Did Madwaleni build the support networks in the community or were they preexisting?
Has ARV treatment had an impact on stigma, in your opinion?

Focus Group with BroadReach Healthcare team in Edendale, 23/11/05
(Themba Duze, Regional Coordinator Gauteng; Bongani Nkosi, Regional Coordinator
Mpumalanga; Zandile Wanda, Regional Coordinator KZN)
-

What is your personal background and how did you enter the field of HIV/AIDS?
Can you speak a bit about the philosophy of BRHC, the idea of the public-private
partnership?
It has been said that the public-private partnership idea has been around for a long
time, but never quite been implemented successfully. What do you think?
What is your perception of stigma in the communities you work in? Do you think
it has changed after BRHC entered the community with ARVs?
What are adherence rates like? In your experience what helps adherence and what
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makes people default?
Interview with Gilles van Cutsem, 16/11/05
- What is your professional background with regard to HIV/AIDS work?
- How are ARVs being delivered in Khayelitsha? What are the processes that
patients have to go through?
- What is the difference to you, treating patients before and after ARVs became
available?
- What was the level of knowledge about HIV/AIDS in the community before MSF
arrived, and the level of stigma?
- What is the philosophy of the ARV treatment programme?
- How do you see medical treatment in the greater context of social conditions e.g.
poverty, malnutrition, unemployment?
- What role do the lay counsellors, support group leaders, and treatment literacy
counsellors have vis-à-vis yourself, the doctors?
- How closely do you work with the TAC and other activist organizations?
- What are the reasons for poor adherence, when it happens, in Khayelitsha? What
are the reasons for such good adherence statistics?
- How do you see the expansion of ART care in South Africa?
Interview with Andrew Boulle, 07/12/05
-

How does the MSF model compare to the ARV rollout in other parts of South
Africa, or for that matter the Madwaleni model and the BroadReach model?
What would the health system ideally look like, if HIV/AIDS care and ART in are
integrated into the system?
How different has it been treating patients pre and post-ARVs?
Has it changed the way you interact with patients?
What is the role of the TAC in Khayelitsha, and do you think that there are many
positive people involved in HIV/AIDS activism?
To what would you attribute the high rates of adherence that MSF reports?
What sort of leadership does the HIV/AIDS movement need? Can the TAC
provide this leadership?
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